Medpace vs its peers
The 10 largest Life Sciences Tools & Services companies by market value, prices of Nov 20, 2026
Medpace is the 8th largest of the 10 biggest Life Sciences Tools & Services companies on OQRO by market value, at $17.1B. Its revenue of $2.53B in fiscal 2025 ranks 9th of 10. It keeps 21% of revenue as operating profit, 3rd of 9 (median 19%). Revenue grew 20% on the year before, against a median of +4.0%. At 37.9x its latest annual earnings, the market prices it close to its peers (median 37.0x).
Side by side
| Company | Market value | Revenue | Growth y/y | 5-yr growth / yr | Gross margin | Operating margin | Net margin | Free cash flow margin | R&D / revenue | Price / earnings | Price / sales | FCF yield | Stock, 12 months |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Thermo Fisher ScientificTMO · FY2025 | $248B | $44.6B | +3.9% | +6.7% | — | 17.4% | 15.0% | 14.1% | 3.1% | 37.0x | 5.6x | 2.5% |
Each company’s latest fiscal year (FY), so the years can end a few months apart. Price ratios divide today’s market value by that year’s figure; price / earnings is left out on a loss. “—” means the company did not tag that line in its annual report.
Operating margin
- WAT25%
- A21%
- MEDP21%
- TECH21%
- DHR19%
- ILMN19%
- TMO17%
- IQV13%
- CRL1%
Compare Medpace head to head
Where Medpace’s revenue comes from and where it goes: Medpace revenue breakdown. Twenty years of results: Medpace financial history.
Common questions
Who are Medpace's competitors?
The largest companies in its industry (Life Sciences Tools & Services) by market value: Thermo Fisher Scientific (TMO), Danaher Corporation (DHR), Agilent Technologies (A), Waters Corporation (WAT), IQVIA (IQV), Mettler Toledo (MTD), Illumina, Inc. (ILMN), Charles River Laboratories (CRL) and Bio-Techne (TECH). They share Medpace's industry listing; not every one competes with it on every product.
Is Medpace bigger than Thermo Fisher Scientific?
No, by market value: Medpace is worth $17.1B and Thermo Fisher Scientific $248B. By revenue, Medpace brought in $2.53B in fiscal 2025 and Thermo Fisher Scientific $44.6B in fiscal 2025.
How does Medpace's valuation compare with its peers?
Where these figures come from
The group is the companies OQRO lists in the same industry as Medpace (Life Sciences Tools & Services), the largest 9 by market value, plus Medpace. Companies whose latest annual report is more than a year and a half old, or that report in a currency other than the dollar, are left out.
Revenue, operating income, net income, gross profit, research and development and free cash flow (cash from operations minus capital expenditure) are each company’s own full-year lines from its latest 10-K, as tagged in XBRL (SEC companyfacts). Market value is the last close times the shares outstanding on the latest filing. Price / earnings is market value over net income; price / sales is market value over revenue; free cash flow yield is free cash flow over market value. Five-year growth is the yearly rate that takes revenue from five fiscal years before to the latest. This page describes the past and is not investment advice. No language model wrote it.









